Industry: Service & Software
Published Date: 2026-03-09
Pages: 105 Pages
Report ld: 6060265
Request Sample
Customized Report
Genome Sequencing Service Market Size(US$)

CAGR 2026-2032
18.0%
Market Size,2032
USD 88,040
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Genome Sequencing Service market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 88040 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Genome Sequencing Service refers to a comprehensive biotechnology service provided by professional organizations, leveraging high-throughput sequencing platforms, bioinformatics analysis technologies, and standardized experimental procedures. This service offers integrated genomic DNA extraction, sequencing, data interpretation, and analysis to clients such as research institutions, medical institutions, and enterprises. Its core principle is to read the base sequences of the entire genome or specific gene fragments of an organism or species using sequencing equipment, and then combine this with bioinformatics tools to analyze the genetic information contained within the sequences. Ultimately, this provides precise genetic data support for basic scientific research, disease diagnosis, agricultural breeding, and other fields.
Clinical diagnosis has long been the core application of this service, and its use continues to deepen. In the field of oncology, sequencing-based targeted therapy has become the mainstream approach, and technologies such as liquid biopsy are driving the service to extend from treatment guidance to early screening. In the field of genetic disease screening, non-invasive prenatal testing has become widespread, and the advancement of the Newborn Genome Project has further expanded the service coverage. Furthermore, sequencing services are increasingly being used for medication guidance in chronic diseases, reducing adverse drug reactions and achieving precision medicine.
Beyond the medical field, sequencing services are rapidly penetrating into agriculture, microbiology, and other fields. In agriculture, sequencing helps uncover genes related to crop stress resistance and high yield, aiding in the breeding of superior varieties and ensuring food security. In the field of microbiology, metagenomic sequencing eliminates the need for strain isolation and culture, enabling the identification of pathogenic microorganisms and analysis of gut microbiota diversity, and is widely used in public health and disease prevention as well as biomedical research and development. Simultaneously, its applications in forensic identification and endangered species protection are also being explored.
The global Genome Sequencing Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Genome Sequencing Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Whole-Genome Sequencing
1.2.3 Whole exome Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Humanity
1.3.3 Plant
1.3.4 Animal
1.3.5 Microorganism
1.3.6 Virus
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Sequencing Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Genome Sequencing Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Genome Sequencing Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Genome Sequencing Service Market Size and Prospective (2021-2032)
2.5.2 Europe Genome Sequencing Service Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Genome Sequencing Service Market Size and Prospective (2021-2032)
2.5.4 Latin America Genome Sequencing Service Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Genome Sequencing Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Genome Sequencing Service Historical Market Size by Type (2021-2026)
3.2 Global Genome Sequencing Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Genome Sequencing Service
4 Breakdown Data by Application
4.1 Global Genome Sequencing Service Historical Market Size by Application (2021-2026)
4.2 Global Genome Sequencing Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Genome Sequencing Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Genome Sequencing Service Players by Revenue (2021-2026)
5.1.2 Global Genome Sequencing Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Genome Sequencing Service Revenue
5.4 Global Genome Sequencing Service Market Concentration Analysis
5.4.1 Global Genome Sequencing Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Genome Sequencing Service Revenue in 2025
5.5 Global Key Players of Genome Sequencing Service Head Offices and Areas Served
5.6 Global Key Players of Genome Sequencing Service, Product and Application
5.7 Global Key Players of Genome Sequencing Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Genome Sequencing Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Genome Sequencing Service Market Size by Type (2021-2026)
6.1.2.2 North America Genome Sequencing Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Genome Sequencing Service Market Size by Application (2021-2026)
6.1.3.2 North America Genome Sequencing Service Market Share by Application (2021-2026)
6.1.4 North America Genome Sequencing Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Genome Sequencing Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Genome Sequencing Service Market Size by Type (2021-2026)
6.2.2.2 Europe Genome Sequencing Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Genome Sequencing Service Market Size by Application (2021-2026)
6.2.3.2 Europe Genome Sequencing Service Market Share by Application (2021-2026)
6.2.4 Europe Genome Sequencing Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Genome Sequencing Service Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Genome Sequencing Service Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Genome Sequencing Service Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Genome Sequencing Service Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Genome Sequencing Service Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Genome Sequencing Service Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Genome Sequencing Service Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Genome Sequencing Service Market Size by Type (2021-2026)
6.4.2.2 Latin America Genome Sequencing Service Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Genome Sequencing Service Market Size by Application (2021-2026)
6.4.3.2 Latin America Genome Sequencing Service Market Share by Application (2021-2026)
6.4.4 Latin America Genome Sequencing Service Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Genome Sequencing Service Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Genome Sequencing Service Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Genome Sequencing Service Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Genome Sequencing Service Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Genome Sequencing Service Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Genome Sequencing Service Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Illumina
7.1.1 Illumina Company Details
7.1.2 Illumina Business Overview
7.1.3 Illumina Genome Sequencing Service Introduction
7.1.4 Illumina Revenue in Genome Sequencing Service Business (2021-2026)
7.1.5 Illumina Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Details
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Genome Sequencing Service Introduction
7.2.4 Thermo Fisher Scientific Revenue in Genome Sequencing Service Business (2021-2026)
7.2.5 Thermo Fisher Scientific Recent Development
7.3 BGI Genomics
7.3.1 BGI Genomics Company Details
7.3.2 BGI Genomics Business Overview
7.3.3 BGI Genomics Genome Sequencing Service Introduction
7.3.4 BGI Genomics Revenue in Genome Sequencing Service Business (2021-2026)
7.3.5 BGI Genomics Recent Development
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Details
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Genome Sequencing Service Introduction
7.4.4 Agilent Technologies Revenue in Genome Sequencing Service Business (2021-2026)
7.4.5 Agilent Technologies Recent Development
7.5 CD Genomics
7.5.1 CD Genomics Company Details
7.5.2 CD Genomics Business Overview
7.5.3 CD Genomics Genome Sequencing Service Introduction
7.5.4 CD Genomics Revenue in Genome Sequencing Service Business (2021-2026)
7.5.5 CD Genomics Recent Development
7.6 Azenta Life Sciences
7.6.1 Azenta Life Sciences Company Details
7.6.2 Azenta Life Sciences Business Overview
7.6.3 Azenta Life Sciences Genome Sequencing Service Introduction
7.6.4 Azenta Life Sciences Revenue in Genome Sequencing Service Business (2021-2026)
7.6.5 Azenta Life Sciences Recent Development
7.7 Broad Clinical Labs
7.7.1 Broad Clinical Labs Company Details
7.7.2 Broad Clinical Labs Business Overview
7.7.3 Broad Clinical Labs Genome Sequencing Service Introduction
7.7.4 Broad Clinical Labs Revenue in Genome Sequencing Service Business (2021-2026)
7.7.5 Broad Clinical Labs Recent Development
7.8 Macrogen
7.8.1 Macrogen Company Details
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Genome Sequencing Service Introduction
7.8.4 Macrogen Revenue in Genome Sequencing Service Business (2021-2026)
7.8.5 Macrogen Recent Development
7.9 GE Healthcare Life Sciences
7.9.1 GE Healthcare Life Sciences Company Details
7.9.2 GE Healthcare Life Sciences Business Overview
7.9.3 GE Healthcare Life Sciences Genome Sequencing Service Introduction
7.9.4 GE Healthcare Life Sciences Revenue in Genome Sequencing Service Business (2021-2026)
7.9.5 GE Healthcare Life Sciences Recent Development
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Details
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Genome Sequencing Service Introduction
7.10.4 Johnson & Johnson Revenue in Genome Sequencing Service Business (2021-2026)
7.10.5 Johnson & Johnson Recent Development
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Details
7.11.2 Abbott Laboratories Business Overview
7.11.3 Abbott Laboratories Genome Sequencing Service Introduction
7.11.4 Abbott Laboratories Revenue in Genome Sequencing Service Business (2021-2026)
7.11.5 Abbott Laboratories Recent Development
7.12 Bayer
7.12.1 Bayer Company Details
7.12.2 Bayer Business Overview
7.12.3 Bayer Genome Sequencing Service Introduction
7.12.4 Bayer Revenue in Genome Sequencing Service Business (2021-2026)
7.12.5 Bayer Recent Development
7.13 Microchip Biotechnologies
7.13.1 Microchip Biotechnologies Company Details
7.13.2 Microchip Biotechnologies Business Overview
7.13.3 Microchip Biotechnologies Genome Sequencing Service Introduction
7.13.4 Microchip Biotechnologies Revenue in Genome Sequencing Service Business (2021-2026)
7.13.5 Microchip Biotechnologies Recent Development
7.14 GeneDx
7.14.1 GeneDx Company Details
7.14.2 GeneDx Business Overview
7.14.3 GeneDx Genome Sequencing Service Introduction
7.14.4 GeneDx Revenue in Genome Sequencing Service Business (2021-2026)
7.14.5 GeneDx Recent Development
7.15 Commonwealth Biotechnologies
7.15.1 Commonwealth Biotechnologies Company Details
7.15.2 Commonwealth Biotechnologies Business Overview
7.15.3 Commonwealth Biotechnologies Genome Sequencing Service Introduction
7.15.4 Commonwealth Biotechnologies Revenue in Genome Sequencing Service Business (2021-2026)
7.15.5 Commonwealth Biotechnologies Recent Development
7.16 ZS Genetics
7.16.1 ZS Genetics Company Details
7.16.2 ZS Genetics Business Overview
7.16.3 ZS Genetics Genome Sequencing Service Introduction
7.16.4 ZS Genetics Revenue in Genome Sequencing Service Business (2021-2026)
7.16.5 ZS Genetics Recent Development
7.17 Pacific Biosciences
7.17.1 Pacific Biosciences Company Details
7.17.2 Pacific Biosciences Business Overview
7.17.3 Pacific Biosciences Genome Sequencing Service Introduction
7.17.4 Pacific Biosciences Revenue in Genome Sequencing Service Business (2021-2026)
7.17.5 Pacific Biosciences Recent Development
7.18 Novogene
7.18.1 Novogene Company Details
7.18.2 Novogene Business Overview
7.18.3 Novogene Genome Sequencing Service Introduction
7.18.4 Novogene Revenue in Genome Sequencing Service Business (2021-2026)
7.18.5 Novogene Recent Development
7.19 Eurofins Genomics
7.19.1 Eurofins Genomics Company Details
7.19.2 Eurofins Genomics Business Overview
7.19.3 Eurofins Genomics Genome Sequencing Service Introduction
7.19.4 Eurofins Genomics Revenue in Genome Sequencing Service Business (2021-2026)
7.19.5 Eurofins Genomics Recent Development
7.20 Psomagen
7.20.1 Psomagen Company Details
7.20.2 Psomagen Business Overview
7.20.3 Psomagen Genome Sequencing Service Introduction
7.20.4 Psomagen Revenue in Genome Sequencing Service Business (2021-2026)
7.20.5 Psomagen Recent Development
8 Genome Sequencing Service Market Dynamics
8.1 Genome Sequencing Service Industry Trends
8.2 Genome Sequencing Service Market Drivers
8.3 Genome Sequencing Service Market Challenges
8.4 Genome Sequencing Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Genome Sequencing Service was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 88040 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 139
USD 3950.00
(Single User License)
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 2900.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 139
USD 3950.00
(Single User License)
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 103
USD 4250.00
(Single User License)
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 160
USD 4900.00
(Single User License)
The global market for Genome Sequencing Service was valued at US$ 23729 million in the year 2024 and is projected to reach a revised size of US$ 75790 million by 2031, growing at a CAGR of 18.0% during the forecast period.
Published Date: 2025-12-12
Pages: 127
USD 2900.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 134
USD 3950.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 169
USD 3950.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 88040 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 139
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 139
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 103
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 160
The global market for Genome Sequencing Service was valued at US$ 23729 million in the year 2024 and is projected to reach a revised size of US$ 75790 million by 2031, growing at a CAGR of 18.0% during the forecast period.
Published: 2025-12-12
Pages: 127
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 134
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 169
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now